Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Chemical Biology (2)
Nature Cell Biology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (2)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cancer
Cell biology
Chemical biology
Physiology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–3 of 3 results

Advanced filters: Author: Michalis Gounis Clear advanced filters

Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG

Louise Fets
Paul C. Driscoll
Dimitrios Anastasiou
Amendments and Corrections23 Oct 2019
Nature Chemical Biology

Volume: 15, P: 1249
Dynamic regulation of integrin β1 phosphorylation supports invasion of breast cancer cells

Conway et al. show that integrin β1 phosphorylation is regulated through balanced activities of tyrosine kinases, such as Src and Arg, and phosphatases, such as PTP-PEST and Shp2, facilitating invadopodia formation and invasion of breast cancer cells.

James R. W. Conway
Omkar Joshi
Johanna Ivaska
ResearchOpen Access26 May 2025
Nature Cell Biology

Volume: 27, P: 1021-1034
MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG

High intracellular concentrations of the α-ketoglutarate analog N-oxalylglycine, owing to MCT2-mediated transport of its newly described prodrug MOG, inhibit multiple enzymes in glutamine metabolism and selectively kill MCT2-expressing cancer cells.

Louise Fets
Paul C. Driscoll
Dimitrios Anastasiou
Research08 Oct 2018
Nature Chemical Biology

Volume: 14, P: 1032-1042

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com footer links

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Filter By:

Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG

Dynamic regulation of integrin β1 phosphorylation supports invasion of breast cancer cells

MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG

Search

Quick links